Suppr超能文献

重新审视通过全外显子组测序分子核型对手术获取的精子进行非整倍体谱分析。

Revisiting aneuploidy profile of surgically retrieved spermatozoa by whole exome sequencing molecular karyotype.

机构信息

The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, New York, United States of America.

Department of Urology, Weill Cornell Medicine, New York, New York, United States of America.

出版信息

PLoS One. 2019 Jan 4;14(1):e0210079. doi: 10.1371/journal.pone.0210079. eCollection 2019.

Abstract

Previous studies, including our own, have reported that spermatozoa isolated from the testis have remarkably higher occurrence of aneuploidy once isolated from azoospermic men. This notion, however, did not translate into a lower pregnancy rate nor a greater proportion of miscarriages. Indeed, ICSI offspring generated from surgically retrieved gametes did not suffer from increased karyotypic aneuploidy than children generated from ejaculated specimens. In recent years, aneuploidy assessments on a larger number of cells and utilizing more chromosome probes have reported a progressive decrease in chromosomal aberrations in spermatozoa directly retrieved from the seminiferous tubules. In light of the availability of more accurate molecular genetic techniques, we have decided to challenge the notion that sampling epididymal and testicular tissues yields spermatozoa with higher incidence of aneuploidy than those retrieved in the ejaculate. In a retrospective manner, we have carried out an analysis by FISH with 9 chromosome probes on at least 1000 cells from the ejaculates of 87 consenting men and the specimens of 6 azoospermic men, while spermatozoa of fertile donors were used as control. Aneuploidy by FISH yielded 0.9% for the donor control but rose in the study group to 3.6% in the ejaculated, 1.2% for the epididymal, and 1.1% for testicular spermatozoa. There were no differences in autosomal or gonosomal disomies, nor nullisomies. In this group, once the specimens of these men were used for ICSI, ejaculated spermatozoa yielded a 22% clinical pregnancy rate that resulted in 62.5% pregnancy loss. The surgically retrieved specimens yielded a 50% clinical pregnancy rate that progressed to term. To confirm our findings, in a prospective analysis, DNA sequencing was carried out on the ejaculates and surgical samples of 22 men with various spermatogenic characteristics. In this comparison, the findings were similar with actually a higher incidence of aneuploidy in the ejaculated spermatozoa (n = 16) compared to those surgically retrieved (n = 6) (P<0.0001). For this group, the clinical pregnancy rate for the ejaculated specimens was 47.2% with 29.4% pregnancy loss, while the surgically retrieved yielded a 50% clinical pregnancy rate, all progressing to term. A subsequent prospective combined assessment on ejaculated and surgically retrieved spermatozoa by FISH and NGS was performed on non-azoospermic men with high DNA fragmentation in their ejaculate. The assessment by FISH evidenced 2.8% chromosomal defects in the ejaculated and 1.2% in testicular biopsies while by NGS became 8.4% and 1.3% (P = 0.02), respectively. Interestingly, we evidenced a pregnancy rate of 0% with ejaculated while 100% with the testicular spermatozoa in this latter group. This indicates that improved techniques for assessing sperm aneuploidy on a wider number of cells disproves earlier reports and corroborates the safe utilization of testicular spermatozoa with a positive impact on chances of pregnancy.

摘要

先前的研究,包括我们自己的研究,已经报道了从无精子症患者中分离的精子在分离后出现非整倍体的发生率显著升高。然而,这种观点并没有转化为更低的妊娠率或更高的流产率。事实上,通过手术获得的配子生成的 ICSI 后代并没有比通过射出样本生成的后代遭受更高的染色体非整倍体。近年来,对更多数量的细胞进行非整倍体评估,并利用更多的染色体探针,报告了从生精小管中直接获取的精子中的染色体结构异常逐渐减少。鉴于更准确的分子遗传技术的可用性,我们决定挑战从附睾和睾丸组织中采样会产生比射出样本中更高发生率的非整倍体的观点。我们以回顾性的方式,对 87 名同意参与的男性的射出样本和 6 名无精子症男性的样本进行了 9 个染色体探针的 FISH 分析,同时使用了可育供体的精子作为对照。FISH 检测的非整倍体率为供体对照的 0.9%,但在研究组中上升到射出样本的 3.6%、附睾样本的 1.2%和睾丸样本的 1.1%。常染色体或性染色体的三体或单体并没有差异。在这组中,一旦这些男性的样本用于 ICSI,射出的精子的临床妊娠率为 22%,导致 62.5%的妊娠丢失。手术获得的标本的临床妊娠率为 50%,并进展到足月。为了证实我们的发现,在一项前瞻性分析中,对 22 名具有不同生精特征的男性的射出样本和手术样本进行了 DNA 测序。在这项比较中,发现实际上射出的精子中非整倍体的发生率更高(n=16),而手术获得的精子(n=6)(P<0.0001)。对于这组患者,射出样本的临床妊娠率为 47.2%,妊娠丢失率为 29.4%,而手术获得的样本的临床妊娠率为 50%,均进展到足月。随后,对具有高射出样本 DNA 碎片的非无精子症男性进行了射出和手术获得的精子的 FISH 和 NGS 联合前瞻性评估。FISH 评估显示射出样本中有 2.8%的染色体缺陷,睾丸活检中有 1.2%,而 NGS 分别为 8.4%和 1.3%(P=0.02)。有趣的是,我们在后者组中发现射出样本的妊娠率为 0%,而睾丸精子的妊娠率为 100%。这表明,对更多数量的细胞进行非整倍体评估的改进技术否定了早期的报告,并证实了安全利用睾丸精子对提高妊娠机会的积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a15/6319716/a9799f1a4fde/pone.0210079.g001.jpg

相似文献

1
Revisiting aneuploidy profile of surgically retrieved spermatozoa by whole exome sequencing molecular karyotype.
PLoS One. 2019 Jan 4;14(1):e0210079. doi: 10.1371/journal.pone.0210079. eCollection 2019.
2
Testicular sperm for intracytoplasmic sperm injection in non-azoospermic men: a paradigm shift.
Panminerva Med. 2019 Jun;61(2):178-186. doi: 10.23736/S0031-0808.18.03534-6.
3
4
Surgically retrieved spermatozoa for ICSI cycles in non-azoospermic males with high sperm DNA fragmentation in semen.
Andrology. 2023 Nov;11(8):1613-1634. doi: 10.1111/andr.13405. Epub 2023 Feb 17.
5
Intracytoplasmic sperm injection (ICSI) in extreme cases of male infertility.
PLoS One. 2014 Dec 1;9(12):e113671. doi: 10.1371/journal.pone.0113671. eCollection 2014.
7
High sex chromosome aneuploidy and diploidy rate of epididymal spermatozoa in obstructive azoospermic men.
J Assist Reprod Genet. 2003 May;20(5):196-203. doi: 10.1023/a:1023674110940.
8
Birth of 16 healthy children after ICSI in cases of nonmosaic Klinefelter syndrome.
Hum Reprod. 2013 May;28(5):1155-60. doi: 10.1093/humrep/det046. Epub 2013 Mar 14.
9
Fertility outcomes after extended searches for ejaculated spermatozoa in men with virtual azoospermia.
Fertil Steril. 2017 Jun;107(6):1305-1311. doi: 10.1016/j.fertnstert.2017.04.005. Epub 2017 May 5.

引用本文的文献

1
The intricate "ART" of ICSI.
J Assist Reprod Genet. 2025 Feb;42(2):349-365. doi: 10.1007/s10815-024-03322-3. Epub 2024 Dec 23.
3
Genetic profiling of azoospermic men to identify the etiology and predict reproductive potential.
J Assist Reprod Genet. 2024 Apr;41(4):1111-1124. doi: 10.1007/s10815-024-03045-5. Epub 2024 Feb 26.
6
Profiling the male germline genome to unravel its reproductive potential.
Fertil Steril. 2023 Feb;119(2):196-206. doi: 10.1016/j.fertnstert.2022.11.006. Epub 2022 Nov 12.
7
Recent advances and controversies in diagnosing and treating male infertility.
Fac Rev. 2020 Dec 10;9:22. doi: 10.12703/r/22. eCollection 2020.
8
Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations.
Andrologia. 2021 Mar;53(2):e13874. doi: 10.1111/and.13874. Epub 2020 Oct 27.
9
Sperm DNA Fragmentation: A New Guideline for Clinicians.
World J Mens Health. 2020 Oct;38(4):412-471. doi: 10.5534/wjmh.200128. Epub 2020 Aug 6.
10
The Use of Testicular Sperm for Intracytoplasmic Sperm Injection in Patients with High Sperm DNA Damage: A Systematic Review.
World J Mens Health. 2021 Jul;39(3):391-398. doi: 10.5534/wjmh.200084. Epub 2020 Jun 25.

本文引用的文献

1
A treatment algorithm for couples with unexplained infertility based on sperm chromatin assessment.
J Assist Reprod Genet. 2018 Oct;35(10):1911-1917. doi: 10.1007/s10815-018-1270-x. Epub 2018 Jul 28.
5
Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences?
J Assist Reprod Genet. 2016 Jul;33(7):823-32. doi: 10.1007/s10815-016-0740-2. Epub 2016 Jun 14.
10
Higher pregnancy rates using testicular sperm in men with severe oligospermia.
Fertil Steril. 2015 Dec;104(6):1382-7. doi: 10.1016/j.fertnstert.2015.08.008. Epub 2015 Sep 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验